These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25680080)

  • 41. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
    Morin JP; Moulin B; Borghi H; Fillastre JP
    Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative properties of angiotensin-converting enzyme inhibitors: relations with inhibition of tissue angiotensin-converting enzyme and potential clinical implications.
    Nash DT
    Am J Cardiol; 1992 Apr; 69(10):26C-32C. PubMed ID: 1312295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging.
    Le D; Brown L; Malik K; Murakami S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities.
    Abouelkheir M
    Curr Mol Pharmacol; 2022; 15(3):582-588. PubMed ID: 34077352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of angiotensin-converting enzyme inhibitors beyond lowering blood pressure--are they important for doctors?
    Holecki M; Szewieczek J; Chudek J
    Pharmacol Rep; 2011; 63(3):740-51. PubMed ID: 21857085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin converting enzyme inhibitors.
    Bauer JH
    Am J Hypertens; 1990 Apr; 3(4):331-7. PubMed ID: 2189445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
    Zou K; Michikawa M
    Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The non-cardiovascular actions of ACE.
    Cao D; Veiras L; Ahmed F; Shibata T; Bernstein EA; Okwan-Duodu D; Giani JF; Khan Z; Bernstein KE
    Peptides; 2022 Jun; 152():170769. PubMed ID: 35182689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamic evaluation of 4 angiotensin-converting enzyme inhibitors in healthy adult horses.
    Afonso T; Giguère S; Rapoport G; Berghaus LJ; Barton MH; Coleman AE
    J Vet Intern Med; 2013; 27(5):1185-92. PubMed ID: 23952255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Joseph Rudinger memorial lecture: Unexpected functions of angiotensin converting enzyme, beyond its enzymatic activity.
    Martinez J
    J Pept Sci; 2017 Oct; 23(10):741-748. PubMed ID: 28626916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.
    Burris JF
    J Clin Pharmacol; 1995 Apr; 35(4):337-42. PubMed ID: 7650220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological implications of MMP-9 inhibition by ACE inhibitors.
    Yamamoto D; Takai S
    Curr Med Chem; 2009; 16(11):1349-54. PubMed ID: 19355890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developmental biology of angiotensin-converting enzyme.
    Yosipiv IV; El-Dahr SS
    Pediatr Nephrol; 1998 Jan; 12(1):72-9. PubMed ID: 9502575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions.
    Kalra J; Prakash A; Kumar P; Majeed AB
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):459-68. PubMed ID: 25944853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validated ligand mapping of ACE active site.
    Kuster DJ; Marshall GR
    J Comput Aided Mol Des; 2005 Aug; 19(8):609-15. PubMed ID: 16307311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties and distribution of angiotensin I converting enzyme.
    Igić R; Behnia R
    Curr Pharm Des; 2003; 9(9):697-706. PubMed ID: 12570787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor.
    d'Alessandro M; Bergantini L; Perrone A; Cameli P; Cameli M; Prasse A; Plataroti D; Sestini P; Bargagli E
    Eur J Intern Med; 2020 Aug; 78():58-62. PubMed ID: 32307232
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.